Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Assets (2021 - 2023)

Historic Return on Assets for Terns Pharmaceuticals (TERN) over the last 3 years, with Q3 2023 value amounting to 0.3%.

  • Terns Pharmaceuticals' Return on Assets rose 500.0% to 0.3% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.3%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.27% for FY2022, which is 1200.0% up from last year.
  • Terns Pharmaceuticals' Return on Assets amounted to 0.3% in Q3 2023, which was up 500.0% from 0.24% recorded in Q2 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Return on Assets peaked at 0.23% during Q1 2023, and registered a low of 0.36% during Q2 2022.
  • Over the past 3 years, Terns Pharmaceuticals' median Return on Assets value was 0.29% (recorded in 2021), while the average stood at 0.29%.
  • In the last 5 years, Terns Pharmaceuticals' Return on Assets crashed by -1200bps in 2022 and then surged by 1100bps in 2023.
  • Terns Pharmaceuticals' Return on Assets (Quarter) stood at 0.29% in 2021, then grew by 13bps to 0.25% in 2022, then decreased by -20bps to 0.3% in 2023.
  • Its last three reported values are 0.3% in Q3 2023, 0.24% for Q2 2023, and 0.23% during Q1 2023.